Login to Your Account



Merck Backs Out of Two Galapagos Partnerships

By Nuala Moran


Wednesday, February 9, 2011
LONDON – Galapagos NV is getting back rights to targets and assays from two collaborations with Merck and Co. Inc. after the big pharma decided it is no longer interested in working with novel targets. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription